The relationship between risk factor levels and presence of coronary artery calcification is dependent on

S L Kardia1, M B Haviland, R E Ferrell

  • 1Department of Human Genetics, University of Michigan, Ann Arbor 48109- 0618, USA. skardia@umich.edu

Insights

Genetic variations in Apolipoprotein E (ApoE) do not directly predict coronary artery calcification (CAC) in asymptomatic adults. However, ApoE genotype influences how traditional risk factors affect CAC development.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Biochemistry

Background:

  • Coronary artery disease (CAD) genetics research aims to improve risk prediction.
  • Identifying young, asymptomatic individuals with coronary atherosclerosis is crucial for early intervention.
  • Coronary artery calcification (CAC) via electron-beam computed tomography is a sensitive marker for coronary atherosclerosis in asymptomatic individuals.

Purpose of the Study:

  • To investigate if Apolipoprotein E (ApoE) genotypes improve the prediction of CAC beyond established risk factors.
  • To determine if ApoE genotype modifies the association between traditional risk factors and CAC presence.

Main Methods:

  • Logistic regression analysis was employed.
  • A study population of 329 asymptomatic adults (169 women, 160 men) aged 20-59 was analyzed.
  • The association between common ApoE genotypes (epsilon3/2, epsilon3/3, epsilon4/3) and CAC presence was assessed.

Main Results:

  • ApoE genotypes did not significantly improve CAC prediction when added to models with individual risk factors (P>0.10).
  • Significant genotype-dependent associations were observed: ApoE genotype influenced the relationship between body mass index, plasma lipids (total cholesterol, ApoB, triglycerides, ApoA1), and CAC in men and women.
  • Specifically, ApoE genotype modulated the impact of body mass index, plasma total cholesterol, and ApoB in men, and body mass index, plasma triglycerides, ApoA1, and ApoE in women on CAC risk.

Conclusions:

  • Apolipoprotein E genotype alone does not enhance the prediction of coronary artery calcification.
  • ApoE genotype plays a role in modulating the influence of established cardiovascular risk factors on the development of CAC.
  • Understanding these gene-environment interactions is key to refining CAD risk assessment.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...